Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations

Vaccine

Volumn 26, Issue 26, 2008, Pages 3261-3267

  Kats, Lev M ^a   Wang, Lina ^a   Murhandarwati, E Elsa Herdiana ^a   Mitri, Khosse ^a   Black, Casilda G ^a   Coppel, Ross L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antibody response; Invasion inhibition; Malaria; Plasmodium; RAMA; Subunit vaccine

Indexed keywords

ECMSP4 5; ECPYRAMA P40; ECPYRAMAE PROTEIN; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 4; MEROZOITE SURFACE PROTEIN 5; PARASITE ANTIGEN; RECOMBINANT PROTEIN; RHOPTRY ASSOCIATED MEMBRANE ANTIGEN; SUBUNIT VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; MALARIA; MALARIA VACCINES; MEMBRANE PROTEINS; MICE; PARASITEMIA; PLASMODIUM YOELII; PROTOZOAN PROTEINS;

EID: 44749092352     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.002     Document Type: Article

References (43)

1. Greenwood B., and Mutabingwa T. Malaria in 2002. Nature 415 February 7 (6872) (2002) 670-672
2. Malkin E., Dubovsky F., and Moree M. Progress towards the development of malaria vaccines. Trends Parasitol 22 July (7) (2006) 292-295
3. Matuschewski K. Vaccine development against malaria. Curr Opin Immunol 18 August (4) (2006) 449-457
4. Ballou W.R., Arevalo-Herrera M., Carucci D., Richie T.L., Corradin G., Diggs C., et al. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg 71 August (2 Suppl.) (2004) 239-247
5. Richie T.L., and Saul A. Progress and challenges for malaria vaccines. Nature 415 February 7 (6872) (2002) 694-701
6. Good M.F. Vaccine-induced immunity to malaria parasites and the need for novel strategies. Trends Parasitol 21 January (1) (2005) 29-34
7. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419 October 3 (6906) (2002) 498-511
8. Bozdech Z., Llinas M., Pulliam B.L., Wong E.D., Zhu J., and DeRisi J.L. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 1 October (1) (2003) E5
9. Le Roch K.G., Zhou Y., Blair P.L., Grainger M., Moch J.K., Haynes J.D., et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301 September 12 (5639) (2003) 1503-1508
10. Wu Y., Sifri C.D., Lei H.H., Su X.Z., and Wellems T.E. Transfection of Plasmodium falciparum within human red blood cells. Proc Natl Acad Sci U. S. A. 92 February14 (44) (1995) 973-977
11. Topolska A.E., Lidgett A., Truman D., Fujioka H., and Coppel R.L. Characterization of a membrane-associated rhoptry protein of Plasmodium falciparum. J Biol Chem 279 February 6 (6) (2004) 4648-4656
12. Topolska A.E., Black C.G., and Coppel R.L. Identification and characterisation of RAMA homologues in rodent, simian and human malaria species. Mol Biochem Parasitol 138 December (2) (2004) 237-241
13. Sanders P.R., Kats L.M., Drew D.R., O'Donnell R.A., O'Neill M., Maier A.G., et al. A set of glycosylphosphatidyl inositol-anchored membrane proteins of Plasmodium falciparum is refractory to genetic deletion. Infect Immunol 74 July (7) (2006) 4330-4338
14. Kar P., Dash A.P., and Supakar P.C. Polymorphism study of rhoptry associated membrane antigen (RAMA) gene of Plasmodium falciparum - a putative vaccine candidate. Mol Biochem Parasitol 155 October (2) (2007) 156-160
15. Nixon C.P., Friedman J., Treanor K., Knopf P.M., Duffy P.E., and Kurtis J.D. Antibodies to rhoptry-associated membrane antigen predict resistance to Plasmodium falciparum. J Infect Dis 192 September 1 (5) (2005) 861-869
16. Topolska A.E., Richie T.L., Nhan D.H., and Coppel R.L. Associations between responses to the rhoptry-associated membrane antigen of Plasmodium falciparum and immunity to malaria infection. Infect Immunol 72 June (6) (2004) 3325-3330
17. Trager W., and Jensen J.B. Human malaria parasites in continuous culture. Science 193 August 20 (4254) (1976) 673-675
18. O'Donnell R.A., de Koning-Ward T.F., Burt R.A., Bockarie M., Reeder J.C., Cowman A.F., et al. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 193 June 18 (12) (2001) 1403-1412
19. Barkan D., Ginsburg H., and Golenser J. Optimisation of flow cytometric measurement of parasitemia in Plasmodium-infected mice. Int J Parasitol 30 April 24 (5) (2000) 649-653
20. Kedzierski L., Black C.G., and Coppel R.L. Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge. Infect Immunol 68 October (10) (2000) 6034-6037
21. Wang L., Kedzierski L., Wesselingh S.L., and Coppel R.L. Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria. Infect Immunol 71 May (5) (2003) 2356-2364
22. Wang L., Goschnick M.W., and Coppel R.L. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge. Infect Immunol 72 October (10) (2004) 6172-6175
23. Kedzierski L., Black C.G., Stowers A.W., Goschnick M.W., Kaslow D.C., and Coppel R.L. Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii. Vaccine 19 September 14 (32) (2001) 4661-4668
24. Kedzierski L., Black C.G., Goschnick M.W., Stowers A.W., and Coppel R.L. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii. Infect Immunol 70 December (12) (2002) 6606-6613
25. Goschnick M.W., Black C.G., Kedzierski L., Holder A.A., and Coppel R.L. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain. Infect Immunol 72 October (10) (2004) 5840-5849
26. Kedzierski L., Black C.G., and Coppel R.L. Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii. Mol Biochem Parasitol 105 January 5 (1) (2000) 137-147
27. Gilson PR, Nebl T, Vukcevic D, Moritz RL, Sargeant T, Speed TP, et al. Identification and stoichiometry of GPI-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics 2006; (April 7).
28. Black C.G., Wang L., Hibbs A.R., Werner E., and Coppel R.L. Identification of the Plasmodium chabaudi homologue of merozoite surface proteins 4 and 5 of Plasmodium falciparum. Infect Immunol 67 May (5) (1999) 2075-2081
29. Howard R.F., Jacobson K.C., Rickel E., and Thurman J. Analysis of inhibitory epitopes in the Plasmodium falciparum rhoptry protein RAP-1 including identification of a second inhibitory epitope. Infect Immunol 66 January (1) (1998) 380-386
30. Ridley R.G., Takacs B., Etlinger H., and Scaife J.G. A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys. Parasitology 101 October (Pt 2) (1990) 187-192
31. Thomas A.W., Deans J.A., Mitchell G.H., Alderson T., and Cohen S. The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol Biochem Parasitol 13 October (2) (1984) 187-199
32. Deans J.A., Alderson T., Thomas A.W., Mitchell G.H., Lennox E.S., and Cohen S. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin Exp Immunol 49 August (2) (1982) 297-309
33. Anders R.F., Crewther P.E., Edwards S., Margetts M., Matthew M.L., Pollock B., et al. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16 January-February (2-3) (1998) 240-247
34. Holder A.A., and Freeman R.R. Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. J Exp Med 156 November 1 (5) (1982) 1528-1538
35. Holder A.A., and Freeman R.R. The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. J Exp Med 160 August 1 (2) (1984) 624-629
36. Narum D.L., and Thomas A.W. Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem Parasitol 67 September (1) (1994) 59-68
37. Healer J., Crawford S., Ralph S., McFadden G., and Cowman A.F. Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites. Infect Immunol 70 October (10) (2002) 5751-5758
38. Richie T. High road, low road? Choices and challenges on the pathway to a malaria vaccine. Parasitology 133 October (Suppl.) (2006) S113-S144
39. Saul A. Kinetic constraints on the development of a malaria vaccine. Parasite Immunol 9 January (1) (1987) 1-9
40. Guevara Patino J.A., Holder A.A., McBride J.S., and Blackman M.J. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J Exp Med 186 November 17 (10) (1997) 1689-1699
41. Nwuba R.I., Sodeinde O., Anumudu C.I., Omosun Y.O., Odaibo A.B., Holder A.A., et al. The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies. Infect Immunol 70 September (9) (2002) 5328-5331
42. Wang L., Kedzierski L., Schofield L., and Coppel R.L. Influence of glycosylphosphatidylinositol anchorage on the efficacy of DNA vaccines encoding Plasmodium yoelii merozoite surface protein 4/5. Vaccine 23 July 14 (432) (2005) 4120-4127
43. Logan G.J., Wang L., Zheng M., Cunningham S.C., Coppel R.L., and Alexander I.E. AAV vectors encoding malarial antigens stimulate antigen-specific immunity but do not protect from parasite infection. Vaccine 25 January 22 (26) (2007) 1014-1022